Free Trial

Herbalife (HLF) Competitors

Herbalife logo
$8.41 +0.69 (+8.93%)
(As of 11/20/2024 ET)

HLF vs. USNA, NUS, NATR, MED, VERU, EL, PBH, IPAR, PETQ, and COSM

Should you be buying Herbalife stock or one of its competitors? The main competitors of Herbalife include USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), PetIQ (PETQ), and Cosmos Health (COSM).

Herbalife vs.

Herbalife (NYSE:HLF) and USANA Health Sciences (NYSE:USNA) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings.

Herbalife received 319 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 67.26% of users gave Herbalife an outperform vote while only 60.55% of users gave USANA Health Sciences an outperform vote.

CompanyUnderperformOutperform
HerbalifeOutperform Votes
715
67.26%
Underperform Votes
348
32.74%
USANA Health SciencesOutperform Votes
396
60.55%
Underperform Votes
258
39.45%

USANA Health Sciences has a net margin of 6.30% compared to Herbalife's net margin of 1.73%. USANA Health Sciences' return on equity of 10.64% beat Herbalife's return on equity.

Company Net Margins Return on Equity Return on Assets
Herbalife1.73% -18.66% 7.12%
USANA Health Sciences 6.30%10.64%8.48%

Herbalife presently has a consensus price target of $9.90, indicating a potential upside of 17.65%. USANA Health Sciences has a consensus price target of $35.00, indicating a potential downside of 11.44%. Given Herbalife's stronger consensus rating and higher possible upside, analysts clearly believe Herbalife is more favorable than USANA Health Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Herbalife
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
USANA Health Sciences
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

54.3% of USANA Health Sciences shares are held by institutional investors. 0.9% of Herbalife shares are held by insiders. Comparatively, 0.3% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Herbalife had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 2 mentions for Herbalife and 0 mentions for USANA Health Sciences. Herbalife's average media sentiment score of 0.08 beat USANA Health Sciences' score of 0.00 indicating that Herbalife is being referred to more favorably in the media.

Company Overall Sentiment
Herbalife Neutral
USANA Health Sciences Neutral

Herbalife has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Herbalife$5.06B0.17$142.20M$0.859.90
USANA Health Sciences$921.01M0.82$63.79M$2.8313.96

Summary

Herbalife beats USANA Health Sciences on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLF vs. The Competition

MetricHerbalifeDrugs, proprietaries, & sundries IndustryRetail SectorNYSE Exchange
Market Cap$778.11M$14.33B$23.96B$19.84B
Dividend YieldN/A1.41%169.97%3.50%
P/E Ratio9.9015.64101.9937.73
Price / Sales0.178.736.5918.01
Price / Cash2.2812.3719.8517.90
Price / Book-0.8912.916.354.86
Net Income$142.20M$776.81M$688.15M$985.93M
7 Day Performance9.07%0.82%-1.23%0.45%
1 Month Performance23.12%5.13%-2.18%1.05%
1 Year Performance-32.55%9.45%15.23%24.67%

Herbalife Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLF
Herbalife
4.1247 of 5 stars
$8.42
+8.9%
$9.90
+17.6%
-33.5%$778.11M$5.06B9.909,200
USNA
USANA Health Sciences
2.8323 of 5 stars
$39.52
+1.2%
$35.00
-11.4%
-14.5%$744.09M$921.01M13.961,800
NUS
Nu Skin Enterprises
3.6991 of 5 stars
$7.49
-1.3%
$8.88
+18.5%
-57.3%$377.31M$1.97B0.003,700
NATR
Nature's Sunshine Products
2.7901 of 5 stars
$16.00
+0.2%
$19.00
+18.8%
-7.5%$295.68M$445.32M18.18814Positive News
MED
Medifast
2.513 of 5 stars
$18.18
+5.0%
$17.00
-6.5%
-73.1%$189.44M$1.07B27.55870Positive News
VERU
Veru
2.3517 of 5 stars
$0.63
flat
$4.00
+539.7%
-36.6%$91.81M$16.30M0.00189Gap Up
EL
Estée Lauder Companies
4.9221 of 5 stars
$65.34
+0.8%
$98.57
+50.9%
-46.6%$23.46B$15.61B116.6862,000Analyst Forecast
Insider Trade
PBH
Prestige Consumer Healthcare
3.3849 of 5 stars
$82.67
+0.3%
$83.67
+1.2%
+40.5%$4.07B$1.13B20.11540
IPAR
Inter Parfums
3.8214 of 5 stars
$127.12
+1.6%
$157.50
+23.9%
+1.8%$4.01B$1.32B27.28530
PETQ
PetIQ
1.8302 of 5 stars
$30.98
flat
$29.67
-4.2%
N/A$925.99M$1.10B79.441,933
COSM
Cosmos Health
1.3169 of 5 stars
$0.72
-2.7%
N/A-35.1%$16.81M$53.38M-0.29123

Related Companies and Tools


This page (NYSE:HLF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners